Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II StudyChristopher G. Willett, Emmanuelle di Tomaso, Dan G. Duda et al.|Journal of Clinical Oncology|2009Cited by 507